Home › Funds › Nantahala Capital Management, LLC › MLYS

Nantahala Capital Management, LLC position in MLYS

MINERALYS THERAPEUTICS INC · Health Care

Nantahala Capital Management, LLC reported holding 689,841 shares of MLYS (MINERALYS THERAPEUTICS INC) in its Q3 2026 13F filing — a position valued at US$17.3M, representing 0.80% of its reported portfolio and ranking #46 among its reported holdings. Nantahala Capital Management, LLC has disclosed MLYS holdings in 11 of the last 11 reported quarters, going back to Q1 2024.

Latest position (Q3 2026)689.84K sh
Reported value held$17.34M
Portfolio Weight0.80%
First reportedQ1 2024
Last changeReduce
Updated2026-11-14

Last updated: 2026-11-14 · Source: SEC EDGAR Form 13F-HR

How Nantahala Capital Management, LLC's MLYS position evolved

Nantahala Capital Management, LLC first disclosed a stake in MLYS in Q1 2024 at 332,506 shares (US$4.3M). The position peaked in Q1 2026 at 895,481 shares, worth US$24.3M. Across 11 filings, Nantahala Capital Management, LLC increased the stake 4 time(s), trimmed it 5 time(s) and left it unchanged 1 time(s). The most recent filing (Q3 2026) shows 689,841 shares valued at US$17.3M — a reduction of -130,640 shares quarter over quarter.. Notable position changes include a 60% increase in Q2 2024 (shares rose 4% over the following quarter), a 55% trim in Q3 2025 (shares fell 4% over the following quarter), a 690% increase in Q1 2026 (shares were roughly flat over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q1 2024 332.51K $4.29M New
Q2 2024 532.51K $6.23M Add
Q3 2024 632.51K $7.66M Add
Q4 2024 632.51K $7.79M Hold
Q1 2025 787.74K $12.51M Add
Q2 2025 353.98K $4.79M Reduce
Q3 2025 158.71K $6.02M Reduce
Q4 2025 113.28K $4.11M Reduce
Q1 2026 895.48K $24.26M Add
Q2 2026 820.48K $22.14M Reduce
Q3 2026 689.84K $17.34M Reduce

Dots on the line are colored by change type; missing quarters mean no position was reported.

About MLYS and 13F data

MLYS (MINERALYS THERAPEUTICS INC) is a Health Care company. 50 other funds we track also report a position in MLYS — the largest reported positions include RA CAPITAL MANAGEMENT, L.P. (US$207.6M), Catalys Pacific, LLC (US$196.0M), Samsara BioCapital, LLC (US$158.4M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding MLYS

All MLYS fund holders →

FAQ

How long has Nantahala Capital Management, LLC held MLYS?

Nantahala Capital Management, LLC has disclosed MLYS holdings in 11 of the last 11 reported quarters, going back to Q1 2024.

What is Nantahala Capital Management, LLC's current position in MLYS?

As of Q3 2026, Nantahala Capital Management, LLC holds 689.84K shares of MLYS (MINERALYS THERAPEUTICS INC), valued at $17.34M, representing 0.80% of its reported portfolio and ranking #46.

Has Nantahala Capital Management, LLC been buying or selling MLYS?

In the latest 13F filing (Q3 2026), Nantahala Capital Management, LLC reduced its position in MLYS. The position peaked in Q1 2026 at 895.48K shares.

Which other funds hold MLYS?

Other major institutional holders of MLYS include RA CAPITAL MANAGEMENT, L.P., Catalys Pacific, LLC, Samsara BioCapital, LLC, among 50 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.